This bill authorizes pharmacists in New Jersey to dispense HIV preexposure prophylaxis (PrEP) and postexposure prophylaxis (PEP) without an individual prescription under specific conditions, including a standing order from the Commissioner of Health. Pharmacists must meet training requirements and follow established protocols, ensuring patients have a negative HIV test and do not show acute HIV symptoms. The bill also mandates that pharmacists notify the patient's primary care provider about the dispensation of these medications unless the patient opts out. Additionally, it allows pharmacists to provide a complete course of PEP to patients who may have been exposed to HIV within the last 72 hours, contingent on meeting clinical criteria and undergoing HIV testing.

Furthermore, the bill requires health insurance contracts to cover PrEP and PEP without prior authorization or step therapy, ensuring that at least one version of the medication is available without these barriers. It limits the supply of PrEP to a maximum of 60 days within a two-year period when dispensed without a prescription. The legislation also prohibits insurance contracts from restricting pharmacists' ability to dispense these medications and mandates that health benefits plans, including Medicaid and state employee health plans, cover PrEP and PEP without prior authorization. Overall, the bill aims to enhance access to HIV prevention and treatment services while ensuring appropriate patient care and follow-up.